These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 24059333)

  • 1. Amyloid-binding compounds and their anti-prion potency.
    Teruya K; Doh-ura K
    Curr Top Med Chem; 2013; 13(19):2522-32. PubMed ID: 24059333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amyloidophilic compounds for prion diseases.
    Teruya K; Kawagoe K; Kimura T; Chen CJ; Sakasegawa Y; Doh-ura K
    Infect Disord Drug Targets; 2009 Feb; 9(1):15-22. PubMed ID: 19200011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo detection of prion amyloid plaques using [(11)C]BF-227 PET.
    Okamura N; Shiga Y; Furumoto S; Tashiro M; Tsuboi Y; Furukawa K; Yanai K; Iwata R; Arai H; Kudo Y; Itoyama Y; Doh-ura K
    Eur J Nucl Med Mol Imaging; 2010 May; 37(5):934-41. PubMed ID: 20016895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Styrylbenzoazole derivatives for imaging of prion plaques and treatment of transmissible spongiform encephalopathies.
    Ishikawa K; Kudo Y; Nishida N; Suemoto T; Sawada T; Iwaki T; Doh-ura K
    J Neurochem; 2006 Oct; 99(1):198-205. PubMed ID: 16987247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A special report I. Prion protein (PrP)--amyloid plaques in the transmissible spongiform encephalopathies, or prion diseases revisited.
    Liberski PP; Bratosiewicz J; Waliś A; Kordek R; Jeffrey M; Brown P
    Folia Neuropathol; 2001; 39(4):217-35. PubMed ID: 11928893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An outline of the neuropathology of transmissible spongiform encephalopathies (prion diseases).
    Liberski PP; Ironside JW
    Folia Neuropathol; 2004; 42 Suppl B():39-58. PubMed ID: 16903141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amyloid plaques in transmissible spongiform encephalopathies (prion diseases).
    Liberski PP
    Folia Neuropathol; 2004; 42 Suppl B():109-19. PubMed ID: 16903146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting prion amyloid deposits in vivo.
    Sadowski M; Pankiewicz J; Scholtzova H; Tsai J; Li Y; Carp RI; Meeker HC; Gambetti P; Debnath M; Mathis CA; Shao L; Gan WB; Klunk WE; Wisniewski T
    J Neuropathol Exp Neurol; 2004 Jul; 63(7):775-84. PubMed ID: 15290902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Creutzfeldt-Jakob disease(CJD) and Gerstmann-Sträussler-Scheinker syndrome(GSS)].
    Udaka F; Fujisawa M; Kameyama M
    Nihon Rinsho; 1997 Apr; 55(4):972-7. PubMed ID: 9103904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A trend of molecular genetics on prion diseases and prion protein].
    Muramatsu Y; Shinagawa M
    Nihon Rinsho; 1993 Sep; 51(9):2494-502. PubMed ID: 8411733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies. Part II].
    Zaborowski A
    Psychiatr Pol; 2004; 38(2):297-309. PubMed ID: 15307294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunolocalization of heparan sulfate proteoglycans to the prion protein amyloid plaques of Gerstmann-Straussler syndrome, Creutzfeldt-Jakob disease and scrapie.
    Snow AD; Wight TN; Nochlin D; Koike Y; Kimata K; DeArmond SJ; Prusiner SB
    Lab Invest; 1990 Nov; 63(5):601-11. PubMed ID: 1977959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prion encephalopathies of animals and humans.
    Prusiner SB
    Dev Biol Stand; 1993; 80():31-44. PubMed ID: 8270114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dominantly inherited prion protein cerebral amyloidoses - a modern view of Gerstmann-Sträussler-Scheinker.
    Ghetti B; Piccardo P; Zanusso G
    Handb Clin Neurol; 2018; 153():243-269. PubMed ID: 29887140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of Styrylbenzoazole Compound and Hydroxypropyl Methylcellulose Enhances Therapeutic Effect in Prion-Infected Mice.
    Teruya K; Oguma A; Iwabuchi S; Nishizawa K; Doh-Ura K
    Mol Neurobiol; 2024 Jul; 61(7):4705-4711. PubMed ID: 38114760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human transmissible spongiform encephalopathies: historic view.
    Asher DM; Gregori L
    Handb Clin Neurol; 2018; 153():1-17. PubMed ID: 29887130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic and infectious prion diseases.
    Prusiner SB
    Arch Neurol; 1993 Nov; 50(11):1129-53. PubMed ID: 8105771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical localization of 14.3.3 zeta protein in amyloid plaques in human spongiform encephalopathies.
    Richard M; Biacabe AG; Streichenberger N; Ironside JW; Mohr M; Kopp N; Perret-Liaudet A
    Acta Neuropathol; 2003 Mar; 105(3):296-302. PubMed ID: 12557018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human prion diseases.
    Thakur R; Vincent YM; Chaturvedi S
    Natl Med J India; 2002; 15(6):339-45. PubMed ID: 12540068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropathology of human prion diseases (spongiform encephalopathies).
    Kretzschmar HA
    Dev Biol Stand; 1993; 80():71-90. PubMed ID: 8270118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.